glp 1 inhibitors drugs GLP-1 Agonists: A Comprehensive Overview GLP-1 Medications | Daniel Stark
Description
Explore a thorough comparison of Semaglutide and other GLP-1 receptor agonists
Is allulose a GLP-1 agonist
Stratified analyses showed no differences between subgroups
Importantly, large-scale randomized trials, meta-analyses, and observational studies suggest that GLP-1RAs do not significantly increase AKI risk and may even confer renal benefits in high-risk populations
Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide
Ph 2 datathat showed weight loss of between 9.4% and 14.7% after 36 weeks on the drug compared to 2.3% for the placebo group and is currently in Ph 3
